期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Mesenchymal stem cell-derived exosomes as a new drug carrier for the treatment of spinal cord injury:A review
1
作者 Lin-Fei Cheng Chao-Qun You +3 位作者 Cheng Peng jia-ji ren Kai Guo Tie-Long Liu 《Chinese Journal of Traumatology》 CAS CSCD 2024年第3期134-146,共13页
Spinal cord injury(SCI)is a devastating traumatic disease seriously impairing the quality of life in patients.Expectations to allow the hopeless central nervous system to repair itself after injury are unfeasible.Deve... Spinal cord injury(SCI)is a devastating traumatic disease seriously impairing the quality of life in patients.Expectations to allow the hopeless central nervous system to repair itself after injury are unfeasible.Developing new approaches to regenerate the central nervous system is still the priority.Exosomes derived from mesenchymal stem cells(MSC-Exo)have been proven to robustly quench the inflammatory response or oxidative stress and curb neuronal apoptosis and autophagy following SCI,which are the key processes to rescue damaged spinal cord neurons and restore their functions.Nonetheless,MSC-Exo in SCI received scant attention.In this review,we reviewed our previous work and other studies to summarize the roles of MSC-Exo in SCI and its underlying mechanisms.Furthermore,we also focus on the application of exosomes as drug carrier in SCI.In particular,it combs the advantages of exosomes as a drug carrier for SCI,imaging advantages,drug types,loading methods,etc.,which provides the latest progress for exosomes in the treatment of SCI,especially drug carrier. 展开更多
关键词 Spinal cord injury Mesenchymal stem cell EXOSOMES Mechanism Drug carrier
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部